Natesto
Payments companies reported to CMS as associated with Natesto. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Natesto, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Natesto
These are the largest totals companies reported as associated with Natesto. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Katherine Gordon | Columbia, SC | Family Medicine | $22.87 |
| Hogai Nassery | Atlanta, GA | Family Medicine | $20.26 |
| Michelle Sariev | Atlanta, GA | Family | $20.25 |
| Sheryl Thacker | Atlanta, GA | Endocrinology, Diabetes & Metabolism | $20.25 |
| Caroline Szyperski | Marietta, GA | Medical | $17.92 |
| Chirag Dave | Marietta, GA | Urology | $17.92 |
| Lacey Ante | Marietta, GA | Surgical | $17.92 |
| Mark Tanner | Atlanta, GA | Family Medicine | $17.80 |
| Robert Wozniak | Rock Hill, SC | Endocrinology, Diabetes & Metabolism | $17.80 |
| Johnnie Lyles | Charlotte, NC | General Practice | $17.02 |
Prescribed Natesto?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.